Shoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

Shoulder Innovations (NYSE: SI) said management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on February 10–11, 2026. The presentation offers an investor update and engagement with industry attendees and analysts.

News Market Reaction – SI

-3.14%

1 alert

-3.14% Session close to close

$262.47M Market Cap

0.1x Rel. Volume

In the Feb 4 session, SI declined 3.14%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights management’s participation in BTIG’s 13th Annual MedTech, Digital Healt...

Analysis

This announcement highlights management’s participation in BTIG’s 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 10–11, 2026, extending a pattern of active conference engagement. Recent history includes strong Q3 2025 revenue of $11.8M (up 58%) and a new product launch in the InSet™ humeral stem line. Investors may watch upcoming financial updates, product adoption metrics, and any follow-on operational disclosures from conference interactions.

Key Figures

Conference edition: 13th Annual Conference start date: February 10, 2026 Conference end date: February 11, 2026 +5 more

8 metrics

Conference edition 13th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Conference start date February 10, 2026 BTIG conference participation day one in Snowbird, UT

Conference end date February 11, 2026 BTIG conference participation day two in Snowbird, UT

Current price $14.25 Pre-news price level on publication date

Daily move 0.64% 24h price change before this conference announcement

Relative volume 1.75x Today’s volume vs 20-day average ahead of BTIG news

52-week range $1.10–$40.25 Trading range prior to this announcement

Q3 2025 revenue $11.8M Quarter reported on Nov 11, 2025, up 58% YoY

Historical Context

5 past events · Latest: Dec 03 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Dec 03	Strategic partnership	Positive	+0.1%	Robotics partnership to enhance precision in shoulder arthroplasty procedures.
Nov 19	Conference participation	Neutral	-4.8%	Management fireside chat at Piper Sandler healthcare conference.
Nov 18	Product launch	Positive	+2.6%	Full commercial launch of InSet™ 70 humeral stem for shoulder arthroplasty.
Nov 11	Earnings results	Positive	+3.2%	Q3 2025 revenue growth of 58% and raised full‑year guidance.
Nov 04	Conference participation	Neutral	+1.1%	CEO presentation at Jefferies Global Healthcare Conference with webcast access.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has generally produced modest, directionally aligned reactions, with stronger moves around product and earnings updates and one notable negative divergence on a conference appearance.

Recent Company History

Over the past few months, Shoulder Innovations reported several operational milestones and investor events. A strategic partnership announced on Dec 3, 2025 for a shoulder-specific robotic platform saw a small positive move. The full commercial launch of the InSet™ 70 humeral stem on Sept 22, 2025 was followed by a 2.63% gain. Q3 2025 results on Nov 11, 2025 featured revenue of $11.8M, up 58%, and a 3.18% rise. Conference participation headlines have produced mixed but generally mild price reactions, providing context for today’s BTIG conference news.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GRAND RAPIDS, Mich., Feb. 3, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the BTIG 13^th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on Tuesday, February 10, 2026 and Wednesday, February 11, 2026. 

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact 
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-participate-in-the-btig-13th-annual-medtech-digital-health-life-science--diagnostic-tools-conference-302677928.html

SOURCE Shoulder Innovations

FAQ

When will Shoulder Innovations (SI) present at the BTIG MedTech conference in 2026?

Management will participate on February 10–11, 2026, providing investor engagement. According to the company, senior management will attend sessions in Snowbird, UT to discuss recent commercial progress and strategic priorities with investors and peers during the two-day event.

Where is the BTIG 13th Annual MedTech conference that SI will attend located?

The conference takes place in Snowbird, Utah, at a resort venue. According to the company, Shoulder Innovations management will be onsite to meet investors, analysts, and industry contacts and to present company developments during the event schedule.

What should investors expect from Shoulder Innovations (SI) at the February 2026 BTIG conference?

Investors can expect management engagement and updates on commercial strategy and shoulder surgical market focus. According to the company, presentations will emphasize recent commercial-stage activities and opportunities to discuss product adoption and go-to-market progress with attendees.

Will Shoulder Innovations (SI) provide a webcast or public materials from the BTIG conference?

The announcement did not specify a webcast or public materials for the event. According to the company, management will participate in conference sessions in person; investors should check the company's investor relations channels for any follow-up materials or summaries.

Who from Shoulder Innovations (SI) will attend the BTIG MedTech conference on February 10–11, 2026?

The release states that members of management will participate, without naming individuals. According to the company, senior management representatives plan to attend conference sessions to engage with investors, analysts, and industry participants over the two-day program.